Meloxicam and Dovonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Dovonex (calcipotriene). Common drug interactions include gait disturbance among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Dovonex. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Dovonex?

Dovonex has active ingredients of calcipotriene. It is often used in psoriasis. eHealthMe is studying from 3,035 Dovonex users. Check the latest studies of Dovonex.

On Jul, 10, 2026

24 people who take Meloxicam and Dovonex together, and have interactions are studied.

Meloxicam and Dovonex drug interactions.

What are the common drug interactions of Meloxicam and Dovonex, by gender? *:

female:

Gait disturbance
Infection
Inflammation
Injection site haemorrhage (bleeding from injection site)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Nasal discharge discolouration (change in colour of nasal discharge)
Nasopharyngitis (inflammation of the nasopharynx)
Pain in extremity
Pancreatitis (inflammation of pancreas)
Regressive behaviour (immature behaviour to ventilate feelings)

male:

Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Chronic kidney disease
Renal failure (kidney dysfunction)

What are the common drug interactions of Meloxicam and Dovonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthralgia (joint pain)
Cyst (a closed sac)
Cyst rupture (fluid leakage from sac)
Cystitis (inflammation of the wall of the bladder)
Drug ineffective
Fungal infection
Gait disturbance
Infection
Inflammation
Injection site haemorrhage (bleeding from injection site)

40-49:

Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Cerebral ataxia (dysfunction of the cerebellum)

50-59:

Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Gingival abscess (pus in gums)
Headache (pain in head)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Muscle spasms (muscle contraction)
Nephrogenic anaemia (anaemia due to kidney disease)
Oligomenorrhoea (infrequent (or, in occasional usage, very light) menstruation)
Renal failure (kidney dysfunction)
Sinusitis (inflammation of sinus)
Uveitis (inflammation of the uvea)

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 37.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 33.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 7 people, 29.17%
Pain: 4 people, 16.67%
High Blood Pressure: 4 people, 16.67%
High Blood Cholesterol: 4 people, 16.67%
Asthma: 3 people, 12.50%
Type 2 Diabetes: 2 people, 8.33%
Multiple Allergies (allergy to multiple agents): 2 people, 8.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Dovonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously